Press Releases

Press Releases

Schrödinger Reports First Quarter 2021 Financial Results and Provides Company Update

First quarter total revenue of $32.1 million , up 23 percent year-over-year; Software revenue of $26.3 million , up 11 percent year-over-year Expanded agreement with AstraZeneca; New agreement with NVIDIA Development candidate selected for MALT1 inhibitor program; Internal pipeline progressing with
May 11, 2021

Schrödinger to Present at the Bank of America Securities 2021 Virtual Healthcare Conference

NEW YORK --(BUSINESS WIRE)--May 4, 2021-- Schrödinger (Nasdaq: SDGR), whose physics-based software platform is transforming the way therapeutics and materials are discovered, today announced that management will provide a corporate overview at the Bank of America Securities 2021 Virtual Healthcare
May 4, 2021

Schrödinger to Host Conference Call to Discuss First Quarter 2021 Financial Results

NEW YORK --(BUSINESS WIRE)--Apr. 27, 2021-- Schrödinger (Nasdaq: SDGR), whose physics-based software platform is transforming the way therapeutics and materials are discovered, today announced that it will host a conference call and webcast on Tuesday, May 11, 2021 , at 8:30 a.m.
April 27, 2021

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

NEW YORK --(BUSINESS WIRE)--Apr. 16, 2021-- Schrödinger, Inc. (Nasdaq: SDGR), whose physics-based software platform is transforming the way therapeutics and materials are discovered, today reported that on April 13, 2021 , the company granted non-statutory stock options to purchase an aggregate of
April 16, 2021

Schrödinger Reports Preclinical Data on Novel, Selective CDC7 Inhibitors Presented at American Association for Cancer Research Annual Meeting

– Data highlight continued progress across internal pipeline; Company continues to plan for multiple IND-enabling studies in 2021 and up to three IND applications in 2022 – – Schrödinger to provide an overview of CDC7, MALT1 and Wee1 programs during a webcast today at 10:00 a.m.
April 12, 2021

Schrödinger to Participate in BMO BioPharma Spotlight Series: Technology-Enabled Drug Discovery

NEW YORK --(BUSINESS WIRE)--Apr. 9, 2021-- Schrödinger (Nasdaq: SDGR), whose physics-based software platform is transforming the way therapeutics and materials are discovered, today announced that Ramy Farid , Ph.D., chief executive officer at Schrödinger, will participate in a panel during the BMO
April 9, 2021

Schrödinger to Host Webcast in Conjunction with Presentation of Preclinical Data for Its CDC7 Program at Virtual AACR Annual Meeting

NEW YORK --(BUSINESS WIRE)--Mar. 30, 2021-- Schrödinger (Nasdaq: SDGR), whose physics-based software platform is transforming the way therapeutics and materials are discovered, today announced that it will host a webcast to review the preclinical data being presented from its CDC7 program during a
March 30, 2021

Schrödinger to Participate in Credit Suisse 2021 Healthcare Innovators Series: The Intersection of Drug Discovery, Drug Development and Artificial Intelligence

NEW YORK --(BUSINESS WIRE)--Mar. 17, 2021-- Schrödinger (Nasdaq: SDGR), whose physics-based software platform is transforming the way therapeutics and materials are discovered, today announced that Ramy Farid , Ph.D., chief executive officer at Schrödinger, will participate in a panel during the
March 17, 2021

Schrödinger Announces Preclinical Data for CDC7 Program to Be Presented at AACR Virtual Annual Meeting 2021

NEW YORK --(BUSINESS WIRE)--Mar. 10, 2021-- Schrödinger (Nasdaq: SDGR), whose physics-based software platform is transforming the way therapeutics and materials are discovered, today announced that preclinical data from its CDC7 program will be presented in a virtual poster session at the American
March 10, 2021

Schrödinger Reports Financial Results for the Fourth Quarter and Full Year 2020 and Provides Outlook for 2021

Total revenue of $108.1 million in 2020, up 26 percent year-over-year Software revenue of $92.5 million in 2020, up 39 percent year-over-year Strong financial position enables continued investment in advancing the science underlying Schrödinger’s computational platform Internal pipeline
March 4, 2021
Displaying 1 - 10 of 14
Back To Top